Evidence map›Paper›PMID 33816089›Full record

ArticlePreventive medicine reports2021

Assessment of cardiovascular disease risks using Framingham risk scores (FRS) in HIV-positive and HIV-negative older adults in South Africa.

Makandwe Nyirenda

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. "Frontiers in public health · 2023
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Makandwe NyirendaSouth African Medical Research Council, Burden of Disease Research Unit, Francie Van Zijl Drive, Cape Town, South Africa.
University of KwaZulu-Natal · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between HIV and cardiovascular diseases (CVDs) remains complex. The aim of this study was to estimate the 10-year CVD risk among HIV-positive and HIV-negative people. The validated Framingham Risk Score (FRS) based on the Framingham Heart study was used to predict the CVD risk. Data for this analysis came from a 2016 cross-sectional study of South African community-dwelling older adults (≥50 years). Logistic regression models were constructed to assess the association between CVD risk and HIV. 403 respondents with a mean age 60 (SD = 6.7) years were enrolled, of whom 70% were female, 75% black African, 21.9% smokers, 77.2% never did any vigorous physical activity, and 17% were HIV-positive. The average 10-year CVD risk was 17%; significantly higher in men than women (23.2 vs 14.3%, p < 0.001). Overall, 33% had low CVD risk (FRS < 10%), 39% intermediate (FRS 10-19%) and 28% high risk (FRS ≥ 20%). Furthermore, participants who were HIV-positive were less likely than HIV-negative participants to have high CVD risk (aOR 0.27, 95% CI 0.11-0.66, p = 0.004). These findings of HIV-positive respondents having lower CVD risk than HIV-negative respondents could be due to three issues i) HIV-positive people having lesser cardio-metabolic disease risk factors; ii) possibly higher health care utilization by HIV-positive people; and/or iii) the neglect of HIV-negative people in HIV focused health systems. Periodic cardiovascular disease monitoring using tools like the Framingham Risk Scores is needed. Furthermore, studies with more robust designs are needed to further elucidate the relationship between HIV and CVD risks in HIV endemic sub-Saharan Africa.

Indexed as

Cardiovascular riskFramingham risk scoreHIVOlder adultsSouth Africa

Identifiers

PMID33816089
PMCPMC8010471
OpenAlexW3138754927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.